

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 8.37870461 |
| 2 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 8.25011618 |
| 3 | keratan sulfate catabolic process (GO:0042340) | 7.88085906 |
| 4 | chondrocyte development (GO:0002063) | 7.77730272 |
| 5 | cartilage condensation (GO:0001502) | 7.04549689 |
| 6 | cell aggregation (GO:0098743) | 7.04549689 |
| 7 | triglyceride catabolic process (GO:0019433) | 7.02851335 |
| 8 | collagen fibril organization (GO:0030199) | 6.51163049 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 6.44147893 |
| 10 | neutral lipid catabolic process (GO:0046461) | 6.31139020 |
| 11 | acylglycerol catabolic process (GO:0046464) | 6.31139020 |
| 12 | notochord development (GO:0030903) | 6.10466330 |
| 13 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.85243142 |
| 14 | sensory perception of smell (GO:0007608) | 5.72617604 |
| 15 | fatty acid homeostasis (GO:0055089) | 5.50371091 |
| 16 | limb bud formation (GO:0060174) | 5.41740121 |
| 17 | endothelial cell morphogenesis (GO:0001886) | 5.22881060 |
| 18 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.81028298 |
| 19 | regulation of endothelial cell differentiation (GO:0045601) | 4.79343937 |
| 20 | NADH metabolic process (GO:0006734) | 4.65591243 |
| 21 | glycerolipid catabolic process (GO:0046503) | 4.44074517 |
| 22 | positive regulation of extracellular matrix organization (GO:1903055) | 4.25355727 |
| 23 | embryonic skeletal joint morphogenesis (GO:0060272) | 4.13378749 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 4.10536441 |
| 25 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.09029411 |
| 26 | collagen catabolic process (GO:0030574) | 4.07378154 |
| 27 | blood vessel maturation (GO:0001955) | 4.07125690 |
| 28 | collagen metabolic process (GO:0032963) | 4.02503118 |
| 29 | positive regulation of chondrocyte differentiation (GO:0032332) | 4.02312972 |
| 30 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.01733179 |
| 31 | regulation of cholesterol storage (GO:0010885) | 4.00106976 |
| 32 | cartilage development (GO:0051216) | 3.93843249 |
| 33 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.93363230 |
| 34 | lipid particle organization (GO:0034389) | 3.89686928 |
| 35 | protein heterotrimerization (GO:0070208) | 3.88516017 |
| 36 | cell migration involved in heart development (GO:0060973) | 3.86422670 |
| 37 | ovulation from ovarian follicle (GO:0001542) | 3.85684670 |
| 38 | biotin metabolic process (GO:0006768) | 3.85193941 |
| 39 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.84209575 |
| 40 | endochondral ossification (GO:0001958) | 3.81914358 |
| 41 | replacement ossification (GO:0036075) | 3.81914358 |
| 42 | response to BMP (GO:0071772) | 3.79652027 |
| 43 | cellular response to BMP stimulus (GO:0071773) | 3.79652027 |
| 44 | multicellular organismal catabolic process (GO:0044243) | 3.78760378 |
| 45 | protein retention in ER lumen (GO:0006621) | 3.77104959 |
| 46 | brown fat cell differentiation (GO:0050873) | 3.75044071 |
| 47 | lipid storage (GO:0019915) | 3.74681838 |
| 48 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.72560874 |
| 49 | connective tissue development (GO:0061448) | 3.71955838 |
| 50 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.71795635 |
| 51 | wound healing, spreading of epidermal cells (GO:0035313) | 3.70436644 |
| 52 | white fat cell differentiation (GO:0050872) | 3.70232576 |
| 53 | sphingomyelin metabolic process (GO:0006684) | 3.69925508 |
| 54 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.69547698 |
| 55 | proteoglycan metabolic process (GO:0006029) | 3.64581535 |
| 56 | barbed-end actin filament capping (GO:0051016) | 3.64048773 |
| 57 | diacylglycerol metabolic process (GO:0046339) | 3.63314321 |
| 58 | multicellular organismal metabolic process (GO:0044236) | 3.62415758 |
| 59 | positive regulation of cartilage development (GO:0061036) | 3.61608166 |
| 60 | ethanol oxidation (GO:0006069) | 3.60149961 |
| 61 | keratan sulfate biosynthetic process (GO:0018146) | 3.58923997 |
| 62 | transcytosis (GO:0045056) | 3.58635969 |
| 63 | response to gravity (GO:0009629) | 3.57986119 |
| 64 | triglyceride biosynthetic process (GO:0019432) | 3.56082547 |
| 65 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.55140098 |
| 66 | response to dietary excess (GO:0002021) | 3.54882041 |
| 67 | chondroitin sulfate biosynthetic process (GO:0030206) | 3.52071866 |
| 68 | chondrocyte proliferation (GO:0035988) | 3.49064725 |
| 69 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.46629506 |
| 70 | iron ion import (GO:0097286) | 3.45187164 |
| 71 | polyol transport (GO:0015791) | 3.45035302 |
| 72 | endodermal cell differentiation (GO:0035987) | 3.44484174 |
| 73 | apoptotic cell clearance (GO:0043277) | 3.42044361 |
| 74 | extracellular matrix disassembly (GO:0022617) | 3.41780609 |
| 75 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.40979261 |
| 76 | sensory perception of chemical stimulus (GO:0007606) | 3.38682084 |
| 77 | regulation of metalloenzyme activity (GO:0048552) | 3.37811778 |
| 78 | neutral lipid biosynthetic process (GO:0046460) | 3.37385584 |
| 79 | acylglycerol biosynthetic process (GO:0046463) | 3.37385584 |
| 80 | extracellular fibril organization (GO:0043206) | 3.35467536 |
| 81 | cellular response to epinephrine stimulus (GO:0071872) | 3.32470099 |
| 82 | positive regulation of lipid storage (GO:0010884) | 3.32057118 |
| 83 | extracellular matrix assembly (GO:0085029) | 3.31409655 |
| 84 | fatty acid transmembrane transport (GO:1902001) | 3.31375908 |
| 85 | triglyceride metabolic process (GO:0006641) | 3.29710252 |
| 86 | cGMP-mediated signaling (GO:0019934) | 3.22023762 |
| 87 | bone trabecula formation (GO:0060346) | 3.21382557 |
| 88 | lymphangiogenesis (GO:0001946) | 3.19375434 |
| 89 | alpha-linolenic acid metabolic process (GO:0036109) | 3.18977511 |
| 90 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.16542518 |
| 91 | negative regulation of granulocyte differentiation (GO:0030853) | 3.16232316 |
| 92 | hypotonic response (GO:0006971) | 3.16113241 |
| 93 | short-term memory (GO:0007614) | 3.14237063 |
| 94 | extracellular matrix organization (GO:0030198) | 3.13962796 |
| 95 | extracellular structure organization (GO:0043062) | 3.13344455 |
| 96 | skeletal system development (GO:0001501) | 3.13262520 |
| 97 | endocardial cushion morphogenesis (GO:0003203) | 3.11417560 |
| 98 | regulation of chondrocyte differentiation (GO:0032330) | 3.10797600 |
| 99 | protein localization to cell surface (GO:0034394) | 3.09144762 |
| 100 | positive regulation of cholesterol efflux (GO:0010875) | 3.06383280 |
| 101 | oxaloacetate metabolic process (GO:0006107) | 3.06381373 |
| 102 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.05395987 |
| 103 | primary alcohol metabolic process (GO:0034308) | 3.04877060 |
| 104 | positive regulation of glucose import (GO:0046326) | 3.04141741 |
| 105 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.03684569 |
| 106 | negative regulation of macrophage differentiation (GO:0045650) | 3.03341097 |
| 107 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.03148687 |
| 108 | myelin assembly (GO:0032288) | 3.02564099 |
| 109 | artery development (GO:0060840) | 3.01584962 |
| 110 | acylglycerol metabolic process (GO:0006639) | 3.01541646 |
| 111 | tricarboxylic acid metabolic process (GO:0072350) | 3.01427071 |
| 112 | daunorubicin metabolic process (GO:0044597) | 3.01302617 |
| 113 | polyketide metabolic process (GO:0030638) | 3.01302617 |
| 114 | doxorubicin metabolic process (GO:0044598) | 3.01302617 |
| 115 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.97807217 |
| 116 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.95274582 |
| 117 | neutral lipid metabolic process (GO:0006638) | 2.95170546 |
| 118 | negative regulation of cartilage development (GO:0061037) | 2.94196140 |
| 119 | keratan sulfate metabolic process (GO:0042339) | 2.93864585 |
| 120 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.93523985 |
| 121 | positive regulation of glomerulus development (GO:0090193) | 2.92556532 |
| 122 | regulation of gonadotropin secretion (GO:0032276) | 2.92243941 |
| 123 | peptidyl-proline hydroxylation (GO:0019511) | 2.91995819 |
| 124 | chemical homeostasis within a tissue (GO:0048875) | 2.91257817 |
| 125 | negative regulation of heart growth (GO:0061117) | 2.89366818 |
| 126 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.89366818 |
| 127 | cyclooxygenase pathway (GO:0019371) | 2.89294655 |
| 128 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.89134447 |
| 129 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.88317862 |
| 130 | response to epinephrine (GO:0071871) | 2.87363782 |
| 131 | membrane raft organization (GO:0031579) | 2.86444830 |
| 132 | regulation of cartilage development (GO:0061035) | 2.85986509 |
| 133 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.85260020 |
| 134 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.85260020 |
| 135 | skin morphogenesis (GO:0043589) | 2.84175329 |
| 136 | phagocytosis, recognition (GO:0006910) | 2.84121114 |
| 137 | lymph vessel development (GO:0001945) | 2.82029381 |
| 138 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.81101691 |
| 139 | surfactant homeostasis (GO:0043129) | 2.79614935 |
| 140 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.79548171 |
| 141 | aminoglycan biosynthetic process (GO:0006023) | 2.79243884 |
| 142 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.79135298 |
| 143 | glycosaminoglycan biosynthetic process (GO:0006024) | 2.79130561 |
| 144 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.78633636 |
| 145 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.78343675 |
| 146 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.78080043 |
| 147 | negative regulation of metanephros development (GO:0072217) | 2.77225874 |
| 148 | positive regulation of vascular permeability (GO:0043117) | 2.75551475 |
| 149 | phosphatidic acid metabolic process (GO:0046473) | 2.74811574 |
| 150 | phosphatidic acid biosynthetic process (GO:0006654) | 2.74811574 |
| 151 | endocrine hormone secretion (GO:0060986) | 2.74291625 |
| 152 | ethanol metabolic process (GO:0006067) | 2.73655227 |
| 153 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.73080232 |
| 154 | cellular response to vitamin (GO:0071295) | 2.72733811 |
| 155 | negative regulation of protein autophosphorylation (GO:0031953) | 2.72321532 |
| 156 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.72080684 |
| 157 | lung vasculature development (GO:0060426) | 2.71866298 |
| 158 | thioester biosynthetic process (GO:0035384) | 2.71755218 |
| 159 | acyl-CoA biosynthetic process (GO:0071616) | 2.71755218 |
| 160 | regulation of lipoprotein metabolic process (GO:0050746) | 2.71510678 |
| 161 | acylglycerol homeostasis (GO:0055090) | 2.70695872 |
| 162 | triglyceride homeostasis (GO:0070328) | 2.70695872 |
| 163 | mesenchyme morphogenesis (GO:0072132) | 2.70601715 |
| 164 | regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393) | 2.68858519 |
| 165 | response to phenylpropanoid (GO:0080184) | 2.68845795 |
| 166 | central nervous system myelination (GO:0022010) | 2.68348927 |
| 167 | axon ensheathment in central nervous system (GO:0032291) | 2.68348927 |
| 168 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.68243287 |
| 169 | regulation of plasminogen activation (GO:0010755) | 2.67629327 |
| 170 | dermatan sulfate biosynthetic process (GO:0030208) | 2.66887756 |
| 171 | stress fiber assembly (GO:0043149) | 2.66646028 |
| 172 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.66364605 |
| 173 | carnitine shuttle (GO:0006853) | 2.65990164 |
| 174 | fibril organization (GO:0097435) | 2.65092091 |
| 175 | glycosaminoglycan catabolic process (GO:0006027) | 2.65006330 |
| 176 | positive regulation of osteoblast proliferation (GO:0033690) | 2.64281116 |
| 177 | chondrocyte differentiation (GO:0002062) | 2.63586886 |
| 178 | wound healing, spreading of cells (GO:0044319) | 2.63531401 |
| 179 | hyperosmotic salinity response (GO:0042538) | 2.63298525 |
| 180 | prostaglandin biosynthetic process (GO:0001516) | 2.61824647 |
| 181 | prostanoid biosynthetic process (GO:0046457) | 2.61824647 |
| 182 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.60259068 |
| 183 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.58648052 |
| 184 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.55665754 |
| 185 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.52889559 |
| 186 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51338261 |
| 187 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.47043717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 7.94954427 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.32530468 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.80292697 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.62522108 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47078526 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.08383413 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87746223 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68074611 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60055676 |
| 10 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.57768515 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.46023759 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.45924816 |
| 13 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.44304739 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42275730 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.40339853 |
| 16 | CJUN_26792858_Chip-Seq_BT549_Human | 2.40095030 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.39827507 |
| 18 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.36281203 |
| 19 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.36281203 |
| 20 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.36281203 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30866226 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30659879 |
| 23 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.09079790 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05301516 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02364294 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01628273 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99989459 |
| 28 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.88009910 |
| 29 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.87719136 |
| 30 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.86247396 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.84187252 |
| 32 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.76500303 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72734855 |
| 34 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64712931 |
| 35 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.63544385 |
| 36 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.62891359 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.62519566 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61197886 |
| 39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.61038061 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60393925 |
| 41 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.59753605 |
| 42 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.59005898 |
| 43 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.58213994 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57706388 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55744287 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55291450 |
| 47 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54636821 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52840310 |
| 49 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49614451 |
| 50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48734832 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48719076 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.48267413 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46984542 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44044756 |
| 55 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43643040 |
| 56 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43643040 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43145660 |
| 58 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41856742 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40473550 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40473550 |
| 61 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.39738678 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38501511 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36649402 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36230773 |
| 65 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.33654754 |
| 66 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.29510325 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29480058 |
| 68 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23367575 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21776155 |
| 70 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21328869 |
| 71 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19985439 |
| 72 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19985439 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.17316977 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16519375 |
| 75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15759711 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.15714615 |
| 77 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15369255 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14246064 |
| 79 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.13681888 |
| 80 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.13614139 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12835808 |
| 82 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.10634676 |
| 83 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10226981 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08591904 |
| 85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08591904 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08063989 |
| 87 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.07624635 |
| 88 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06267495 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06127980 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05880699 |
| 91 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.05876577 |
| 92 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02864986 |
| 93 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.01742525 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.01263154 |
| 95 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00912745 |
| 96 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00817058 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00539903 |
| 98 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.00027612 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99132697 |
| 100 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98741282 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98312662 |
| 102 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.98207488 |
| 103 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.97716694 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97243060 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96651182 |
| 106 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95355979 |
| 107 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94927495 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93477767 |
| 109 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.92728919 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92432942 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92422522 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92383934 |
| 113 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.92256744 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92009416 |
| 115 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91659033 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91402117 |
| 117 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90816688 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89542088 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88093309 |
| 120 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88044672 |
| 121 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88021088 |
| 122 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87983916 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87420968 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87350438 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85491375 |
| 126 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.84992161 |
| 127 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84957520 |
| 128 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.84164661 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83703289 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83314832 |
| 131 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83220876 |
| 132 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83208120 |
| 133 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82881613 |
| 134 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81472541 |
| 135 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81329250 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81183509 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81133410 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80540470 |
| 139 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80409236 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79471917 |
| 141 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.77716415 |
| 142 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.76932062 |
| 143 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75014582 |
| 144 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.74074853 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.70620130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.10417236 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.36345135 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.82844611 |
| 4 | MP0005275_abnormal_skin_tensile | 4.01512259 |
| 5 | MP0005666_abnormal_adipose_tissue | 3.93276147 |
| 6 | MP0004134_abnormal_chest_morphology | 3.55671278 |
| 7 | MP0001958_emphysema | 3.44802498 |
| 8 | MP0002933_joint_inflammation | 3.42240996 |
| 9 | MP0002282_abnormal_trachea_morphology | 3.20881333 |
| 10 | MP0004130_abnormal_muscle_cell | 3.17193263 |
| 11 | MP0005375_adipose_tissue_phenotype | 2.95024468 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.88815046 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.87339210 |
| 14 | MP0002971_abnormal_brown_adipose | 2.80956836 |
| 15 | MP0009250_abnormal_appendicular_skeleto | 2.78181339 |
| 16 | MP0001542_abnormal_bone_strength | 2.66048060 |
| 17 | MP0000163_abnormal_cartilage_morphology | 2.64920727 |
| 18 | MP0005508_abnormal_skeleton_morphology | 2.54359832 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.48708737 |
| 20 | MP0001984_abnormal_olfaction | 2.46494297 |
| 21 | MP0003279_aneurysm | 2.34684903 |
| 22 | MP0006138_congestive_heart_failure | 2.30245541 |
| 23 | MP0008004_abnormal_stomach_pH | 2.23612034 |
| 24 | MP0004272_abnormal_basement_membrane | 2.11809968 |
| 25 | MP0000762_abnormal_tongue_morphology | 2.11717635 |
| 26 | MP0002115_abnormal_skeleton_extremities | 2.05159943 |
| 27 | MP0003646_muscle_fatigue | 2.03379243 |
| 28 | MP0010368_abnormal_lymphatic_system | 2.02698873 |
| 29 | MP0001299_abnormal_eye_distance/ | 1.98103562 |
| 30 | MP0009115_abnormal_fat_cell | 1.92508824 |
| 31 | MP0002896_abnormal_bone_mineralization | 1.88314558 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.85261758 |
| 33 | MP0003011_delayed_dark_adaptation | 1.84156442 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.81153306 |
| 35 | MP0003283_abnormal_digestive_organ | 1.80798854 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.79266284 |
| 37 | MP0002113_abnormal_skeleton_development | 1.75741431 |
| 38 | MP0001661_extended_life_span | 1.73250334 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.72774979 |
| 40 | MP0002295_abnormal_pulmonary_circulatio | 1.69429201 |
| 41 | MP0000751_myopathy | 1.69291473 |
| 42 | MP0003959_abnormal_lean_body | 1.67125339 |
| 43 | MP0005390_skeleton_phenotype | 1.66887988 |
| 44 | MP0002970_abnormal_white_adipose | 1.65433796 |
| 45 | MP0003828_pulmonary_edema | 1.63220387 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.62791626 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.56839457 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.54616400 |
| 49 | MP0002233_abnormal_nose_morphology | 1.53711142 |
| 50 | MP0005334_abnormal_fat_pad | 1.49211105 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.48867209 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.48742596 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.48551218 |
| 54 | MP0003755_abnormal_palate_morphology | 1.47322920 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 1.43212502 |
| 56 | MP0005385_cardiovascular_system_phenoty | 1.43212502 |
| 57 | MP0005023_abnormal_wound_healing | 1.42677329 |
| 58 | MP0004087_abnormal_muscle_fiber | 1.37543701 |
| 59 | MP0000343_altered_response_to | 1.36229014 |
| 60 | MP0002109_abnormal_limb_morphology | 1.36136806 |
| 61 | MP0000049_abnormal_middle_ear | 1.29081645 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.26822040 |
| 63 | MP0004215_abnormal_myocardial_fiber | 1.24724181 |
| 64 | MP0003868_abnormal_feces_composition | 1.23515910 |
| 65 | MP0002060_abnormal_skin_morphology | 1.22850753 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.22529794 |
| 67 | MP0004036_abnormal_muscle_relaxation | 1.21948835 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.21162633 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.20047570 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.17922291 |
| 71 | MP0003091_abnormal_cell_migration | 1.15844117 |
| 72 | MP0002116_abnormal_craniofacial_bone | 1.15461525 |
| 73 | MP0002972_abnormal_cardiac_muscle | 1.13168958 |
| 74 | MP0000432_abnormal_head_morphology | 1.12741236 |
| 75 | MP0003795_abnormal_bone_structure | 1.11234680 |
| 76 | MP0005535_abnormal_body_temperature | 1.10254102 |
| 77 | MP0002249_abnormal_larynx_morphology | 1.09965514 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 1.08137789 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 1.04201951 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 1.04114146 |
| 81 | MP0005330_cardiomyopathy | 1.03912939 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 1.03873242 |
| 83 | MP0000749_muscle_degeneration | 1.03084765 |
| 84 | MP0001270_distended_abdomen | 1.02838730 |
| 85 | MP0002111_abnormal_tail_morphology | 1.01951565 |
| 86 | MP0003935_abnormal_craniofacial_develop | 1.00701676 |
| 87 | MP0002653_abnormal_ependyma_morphology | 0.99488231 |
| 88 | MP0005452_abnormal_adipose_tissue | 0.97190089 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.96857756 |
| 90 | MP0005164_abnormal_response_to | 0.96344967 |
| 91 | MP0010630_abnormal_cardiac_muscle | 0.95486125 |
| 92 | MP0002932_abnormal_joint_morphology | 0.94932246 |
| 93 | MP0003941_abnormal_skin_development | 0.94170446 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 0.94060872 |
| 95 | MP0000516_abnormal_urinary_system | 0.94060872 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.93685195 |
| 97 | MP0000747_muscle_weakness | 0.92645377 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.92440526 |
| 99 | MP0002133_abnormal_respiratory_system | 0.91462454 |
| 100 | MP0005388_respiratory_system_phenotype | 0.91462454 |
| 101 | MP0004133_heterotaxia | 0.91162724 |
| 102 | MP0004484_altered_response_of | 0.89630924 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.89132346 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.88952075 |
| 105 | MP0005171_absent_coat_pigmentation | 0.88912051 |
| 106 | MP0003385_abnormal_body_wall | 0.86271870 |
| 107 | MP0003942_abnormal_urinary_system | 0.83525616 |
| 108 | MP0002114_abnormal_axial_skeleton | 0.82156030 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.81850648 |
| 110 | MP0005165_increased_susceptibility_to | 0.81784151 |
| 111 | MP0001177_atelectasis | 0.81736477 |
| 112 | MP0000566_synostosis | 0.80168480 |
| 113 | MP0005448_abnormal_energy_balance | 0.80039952 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.79834794 |
| 115 | MP0003123_paternal_imprinting | 0.79333821 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.78425332 |
| 117 | MP0005647_abnormal_sex_gland | 0.77753150 |
| 118 | MP0003690_abnormal_glial_cell | 0.76991513 |
| 119 | MP0005499_abnormal_olfactory_system | 0.76149492 |
| 120 | MP0005394_taste/olfaction_phenotype | 0.76149492 |
| 121 | MP0002269_muscular_atrophy | 0.74396280 |
| 122 | MP0005257_abnormal_intraocular_pressure | 0.74249495 |
| 123 | MP0004233_abnormal_muscle_weight | 0.73358143 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.72531172 |
| 125 | MP0000733_abnormal_muscle_development | 0.70222793 |
| 126 | MP0001175_abnormal_lung_morphology | 0.69754513 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.69570850 |
| 128 | MP0000249_abnormal_blood_vessel | 0.69379173 |
| 129 | MP0005365_abnormal_bile_salt | 0.68965088 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.68087129 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.68030737 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.66286862 |
| 133 | MP0001881_abnormal_mammary_gland | 0.64345875 |
| 134 | MP0004858_abnormal_nervous_system | 0.63506839 |
| 135 | MP0000003_abnormal_adipose_tissue | 0.63444859 |
| 136 | MP0002168_other_aberrant_phenotype | 0.63053558 |
| 137 | MP0010352_gastrointestinal_tract_polyps | 0.62484693 |
| 138 | MP0002638_abnormal_pupillary_reflex | 0.61916868 |
| 139 | MP0003724_increased_susceptibility_to | 0.61525142 |
| 140 | MP0001614_abnormal_blood_vessel | 0.60746283 |
| 141 | MP0003186_abnormal_redox_activity | 0.60707392 |
| 142 | MP0001293_anophthalmia | 0.60090016 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.59430994 |
| 144 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58415210 |
| 145 | MP0003948_abnormal_gas_homeostasis | 0.57766595 |
| 146 | MP0005369_muscle_phenotype | 0.57562808 |
| 147 | MP0001243_abnormal_dermal_layer | 0.57450607 |
| 148 | MP0002128_abnormal_blood_circulation | 0.55501474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 8.25131080 |
| 2 | Irregular epiphyses (HP:0010582) | 8.10443242 |
| 3 | Vitreoretinal degeneration (HP:0000655) | 6.68110107 |
| 4 | Hypoplastic ischia (HP:0003175) | 5.81152866 |
| 5 | Small epiphyses (HP:0010585) | 5.55356671 |
| 6 | Cupped ribs (HP:0000887) | 5.39332982 |
| 7 | Abnormality of the ischium (HP:0003174) | 5.17014110 |
| 8 | Abnormal tarsal ossification (HP:0008369) | 5.02355366 |
| 9 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.87728198 |
| 10 | Flat capital femoral epiphysis (HP:0003370) | 4.87364445 |
| 11 | Genu varum (HP:0002970) | 4.67676758 |
| 12 | Flat acetabular roof (HP:0003180) | 4.52664678 |
| 13 | Oligomenorrhea (HP:0000876) | 4.48190393 |
| 14 | Delayed epiphyseal ossification (HP:0002663) | 4.23792226 |
| 15 | Acanthosis nigricans (HP:0000956) | 4.15380744 |
| 16 | Aortic aneurysm (HP:0004942) | 4.15309207 |
| 17 | Vertebral compression fractures (HP:0002953) | 4.14303140 |
| 18 | Neonatal short-limb short stature (HP:0008921) | 4.13914533 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 4.05007896 |
| 20 | Abnormality of femoral epiphyses (HP:0006499) | 4.01610238 |
| 21 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 4.01610238 |
| 22 | Osteoarthritis (HP:0002758) | 3.83501209 |
| 23 | Flattened epiphyses (HP:0003071) | 3.80390812 |
| 24 | Absent epiphyses (HP:0010577) | 3.77102765 |
| 25 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 3.77102765 |
| 26 | Mild short stature (HP:0003502) | 3.76046555 |
| 27 | Hypertriglyceridemia (HP:0002155) | 3.75186981 |
| 28 | Metaphyseal cupping (HP:0003021) | 3.66452832 |
| 29 | Abnormal foot bone ossification (HP:0010675) | 3.62900479 |
| 30 | Arthropathy (HP:0003040) | 3.59374567 |
| 31 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 3.58480234 |
| 32 | Abnormality of the vertebral endplates (HP:0005106) | 3.58175953 |
| 33 | Complement deficiency (HP:0004431) | 3.56182071 |
| 34 | Shallow orbits (HP:0000586) | 3.53272838 |
| 35 | Broad metatarsal (HP:0001783) | 3.45744975 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.44686391 |
| 37 | Abnormality of the femoral head (HP:0003368) | 3.33593246 |
| 38 | Vascular tortuosity (HP:0004948) | 3.28188660 |
| 39 | Coxa vara (HP:0002812) | 3.27432040 |
| 40 | Premature rupture of membranes (HP:0001788) | 3.26547533 |
| 41 | Soft skin (HP:0000977) | 3.25893949 |
| 42 | Cervical subluxation (HP:0003308) | 3.25785950 |
| 43 | Abnormality of complement system (HP:0005339) | 3.24430255 |
| 44 | Short femoral neck (HP:0100864) | 3.21663100 |
| 45 | Irregular vertebral endplates (HP:0003301) | 3.18617845 |
| 46 | Myocardial infarction (HP:0001658) | 3.18235534 |
| 47 | Aortic dissection (HP:0002647) | 3.08025359 |
| 48 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.06993072 |
| 49 | Lipoatrophy (HP:0100578) | 3.05856563 |
| 50 | Pulmonary artery stenosis (HP:0004415) | 2.97867314 |
| 51 | Beaking of vertebral bodies (HP:0004568) | 2.96464790 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.94771036 |
| 53 | Platyspondyly (HP:0000926) | 2.93452171 |
| 54 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.91347823 |
| 55 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.86391518 |
| 56 | Mitral stenosis (HP:0001718) | 2.85673753 |
| 57 | Wrist flexion contracture (HP:0001239) | 2.82553322 |
| 58 | Abnormality of the pubic bones (HP:0003172) | 2.80353094 |
| 59 | Metaphyseal irregularity (HP:0003025) | 2.79389737 |
| 60 | Abnormal vertebral ossification (HP:0100569) | 2.78527803 |
| 61 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.77092075 |
| 62 | Ectopia lentis (HP:0001083) | 2.76103682 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.73319291 |
| 64 | Carpal bone hypoplasia (HP:0001498) | 2.73183257 |
| 65 | Metaphyseal dysplasia (HP:0100255) | 2.71000507 |
| 66 | Bladder diverticulum (HP:0000015) | 2.68361480 |
| 67 | Abnormality of carpal bone ossification (HP:0006257) | 2.65843331 |
| 68 | Insulin resistance (HP:0000855) | 2.65281368 |
| 69 | Skin nodule (HP:0200036) | 2.64369556 |
| 70 | Overgrowth (HP:0001548) | 2.63702860 |
| 71 | Thoracolumbar scoliosis (HP:0002944) | 2.63364110 |
| 72 | Barrel-shaped chest (HP:0001552) | 2.62496164 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 2.62037029 |
| 74 | Back pain (HP:0003418) | 2.60339786 |
| 75 | Stillbirth (HP:0003826) | 2.59231341 |
| 76 | Arterial tortuosity (HP:0005116) | 2.58796408 |
| 77 | Protuberant abdomen (HP:0001538) | 2.58447452 |
| 78 | Vertebral clefting (HP:0008428) | 2.55437180 |
| 79 | Broad ribs (HP:0000885) | 2.53076312 |
| 80 | Ulnar bowing (HP:0003031) | 2.52581792 |
| 81 | Hypoplasia of the odontoid process (HP:0003311) | 2.50452587 |
| 82 | Limited elbow extension (HP:0001377) | 2.50184143 |
| 83 | Limited hip movement (HP:0008800) | 2.49488715 |
| 84 | Waddling gait (HP:0002515) | 2.47983208 |
| 85 | Aortic valve stenosis (HP:0001650) | 2.47922915 |
| 86 | Biconcave vertebral bodies (HP:0004586) | 2.46644557 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 2.45688784 |
| 88 | Ovoid vertebral bodies (HP:0003300) | 2.44904836 |
| 89 | Thin ribs (HP:0000883) | 2.44437472 |
| 90 | Striae distensae (HP:0001065) | 2.43195547 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40269541 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.40269541 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.39856295 |
| 94 | Abnormality of incisor morphology (HP:0011063) | 2.39143346 |
| 95 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.38471538 |
| 96 | Mitral valve prolapse (HP:0001634) | 2.37565671 |
| 97 | Long clavicles (HP:0000890) | 2.37150393 |
| 98 | Hip contracture (HP:0003273) | 2.35432689 |
| 99 | Spinal cord compression (HP:0002176) | 2.35428828 |
| 100 | Blue sclerae (HP:0000592) | 2.30235261 |
| 101 | Abnormality of the acetabulum (HP:0003170) | 2.28775843 |
| 102 | Absent frontal sinuses (HP:0002688) | 2.28493874 |
| 103 | Round ear (HP:0100830) | 2.27731022 |
| 104 | Increased serum pyruvate (HP:0003542) | 2.25075485 |
| 105 | Hyperlipoproteinemia (HP:0010980) | 2.22576005 |
| 106 | Patent foramen ovale (HP:0001655) | 2.22553304 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.22099643 |
| 108 | Glossoptosis (HP:0000162) | 2.20455876 |
| 109 | Coronal craniosynostosis (HP:0004440) | 2.20452164 |
| 110 | Mesomelia (HP:0003027) | 2.20174073 |
| 111 | Abnormality of the vitreous humor (HP:0004327) | 2.19638885 |
| 112 | Hypoalphalipoproteinemia (HP:0003233) | 2.18723766 |
| 113 | Abnormality of the odontoid process (HP:0003310) | 2.18516461 |
| 114 | Enlarged epiphyses (HP:0010580) | 2.18325015 |
| 115 | Difficulty running (HP:0009046) | 2.17160983 |
| 116 | Wormian bones (HP:0002645) | 2.15739745 |
| 117 | Mitral regurgitation (HP:0001653) | 2.14557205 |
| 118 | Genu recurvatum (HP:0002816) | 2.12999784 |
| 119 | Lumbar hyperlordosis (HP:0002938) | 2.12033459 |
| 120 | Joint stiffness (HP:0001387) | 2.11795542 |
| 121 | Hypercortisolism (HP:0001578) | 2.09067859 |
| 122 | Neck muscle weakness (HP:0000467) | 2.08401329 |
| 123 | Vertebral hypoplasia (HP:0008417) | 2.07974064 |
| 124 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.07974064 |
| 125 | Atrioventricular block (HP:0001678) | 2.07836693 |
| 126 | Abnormal ossification of hand bones (HP:0005921) | 2.07552370 |
| 127 | Axonal loss (HP:0003447) | 2.07239229 |
| 128 | Exostoses (HP:0100777) | 2.06159717 |
| 129 | Micromelia (HP:0002983) | 2.04967906 |
| 130 | Polycythemia (HP:0001901) | 2.04924643 |
| 131 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.04909978 |
| 132 | Joint laxity (HP:0001388) | 2.04847552 |
| 133 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.03937872 |
| 134 | Cardiovascular calcification (HP:0011915) | 2.03587908 |
| 135 | Infantile muscular hypotonia (HP:0008947) | 2.03056489 |
| 136 | Fibular hypoplasia (HP:0003038) | 2.02665328 |
| 137 | Abnormal hand bone ossification (HP:0010660) | 2.02272456 |
| 138 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02172857 |
| 139 | Nausea (HP:0002018) | 2.01482979 |
| 140 | Abnormality of the 2nd finger (HP:0004100) | 2.01001672 |
| 141 | Hyporeflexia of lower limbs (HP:0002600) | 2.00915563 |
| 142 | Distal lower limb muscle weakness (HP:0009053) | 2.00775076 |
| 143 | Muscle fiber splitting (HP:0003555) | 2.00435682 |
| 144 | Broad phalanx (HP:0006009) | 1.99751758 |
| 145 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.99684218 |
| 146 | Abnormality of glycolysis (HP:0004366) | 1.99280566 |
| 147 | Aneurysm (HP:0002617) | 1.98652047 |
| 148 | Radial bowing (HP:0002986) | 1.98451304 |
| 149 | Nuclear cataract (HP:0100018) | 1.98397619 |
| 150 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.96435257 |
| 151 | Follicular hyperkeratosis (HP:0007502) | 1.95582599 |
| 152 | Broad long bones (HP:0005622) | 1.95582440 |
| 153 | Spinal cord lesions (HP:0100561) | 1.95134503 |
| 154 | Syringomyelia (HP:0003396) | 1.95134503 |
| 155 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93758820 |
| 156 | Hypercholesterolemia (HP:0003124) | 1.93501867 |
| 157 | Hypoplasia of the iris (HP:0007676) | 1.93178132 |
| 158 | Spinal rigidity (HP:0003306) | 1.92832316 |
| 159 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.91953048 |
| 160 | Abnormality of dentin (HP:0010299) | 1.91904239 |
| 161 | Ankle contracture (HP:0006466) | 1.90062017 |
| 162 | Abnormality of alanine metabolism (HP:0010916) | 1.89680741 |
| 163 | Hyperalaninemia (HP:0003348) | 1.89680741 |
| 164 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89680741 |
| 165 | Xanthomatosis (HP:0000991) | 1.87347561 |
| 166 | Hyperextensible skin (HP:0000974) | 1.87085977 |
| 167 | Disproportionate short-trunk short stature (HP:0003521) | 1.87011684 |
| 168 | Severe Myopia (HP:0011003) | 1.86011100 |
| 169 | Short nail (HP:0001799) | 1.85765909 |
| 170 | Ventricular tachycardia (HP:0004756) | 1.85363063 |
| 171 | Hemorrhage of the eye (HP:0011885) | 1.85145443 |
| 172 | Venous abnormality (HP:0002624) | 1.84874851 |
| 173 | Dilated cardiomyopathy (HP:0001644) | 1.84385673 |
| 174 | Delayed cranial suture closure (HP:0000270) | 1.83032835 |
| 175 | Abnormal delivery (HP:0001787) | 1.82888074 |
| 176 | Sudden death (HP:0001699) | 1.81899325 |
| 177 | Abnormal atrioventricular conduction (HP:0005150) | 1.79902324 |
| 178 | Increased connective tissue (HP:0009025) | 1.79767577 |
| 179 | Subcapsular cataract (HP:0000523) | 1.79656675 |
| 180 | Short middle phalanx of finger (HP:0005819) | 1.79216952 |
| 181 | Hypoplastic scapulae (HP:0000882) | 1.79211966 |
| 182 | Elbow flexion contracture (HP:0002987) | 1.78970284 |
| 183 | Atrial fibrillation (HP:0005110) | 1.78779139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 6.09679090 |
| 2 | MAP3K3 | 4.71883046 |
| 3 | MYLK | 4.37620097 |
| 4 | STK38L | 4.05418002 |
| 5 | ERBB3 | 3.89155946 |
| 6 | TIE1 | 3.31582451 |
| 7 | STK24 | 3.27655451 |
| 8 | PRKG2 | 2.44036680 |
| 9 | TGFBR2 | 2.33198686 |
| 10 | PHKG2 | 2.29945191 |
| 11 | PHKG1 | 2.29945191 |
| 12 | TRPM7 | 2.22544770 |
| 13 | ARAF | 2.08128317 |
| 14 | ERN1 | 2.01329869 |
| 15 | PRKAA2 | 1.98036188 |
| 16 | ABL2 | 1.91083542 |
| 17 | TTN | 1.85170554 |
| 18 | MAP3K6 | 1.82319061 |
| 19 | MAPKAPK3 | 1.67455778 |
| 20 | PLK2 | 1.66746428 |
| 21 | MST4 | 1.63206281 |
| 22 | STK39 | 1.55596603 |
| 23 | MET | 1.55578708 |
| 24 | TRIB3 | 1.54145644 |
| 25 | LIMK1 | 1.50621788 |
| 26 | LATS2 | 1.48558671 |
| 27 | PIM2 | 1.47371599 |
| 28 | EPHA2 | 1.45917928 |
| 29 | FER | 1.45036205 |
| 30 | CAMK1 | 1.42923021 |
| 31 | EEF2K | 1.37695436 |
| 32 | LATS1 | 1.34285752 |
| 33 | PDK2 | 1.32900181 |
| 34 | DMPK | 1.30787927 |
| 35 | PAK3 | 1.23884780 |
| 36 | EPHB2 | 1.23838102 |
| 37 | MAPK15 | 1.15022074 |
| 38 | MOS | 1.13246518 |
| 39 | ERBB4 | 1.12610223 |
| 40 | CAMK1G | 1.11578552 |
| 41 | STK3 | 1.11551836 |
| 42 | CDK9 | 1.10273117 |
| 43 | EIF2AK3 | 1.09645408 |
| 44 | PRPF4B | 1.08961359 |
| 45 | NME1 | 1.08226277 |
| 46 | CAMK2D | 1.06363413 |
| 47 | NME2 | 1.03925304 |
| 48 | TESK1 | 1.03082290 |
| 49 | PRKAA1 | 0.99568103 |
| 50 | ILK | 0.97037263 |
| 51 | MAPK4 | 0.95469041 |
| 52 | PDGFRB | 0.95088160 |
| 53 | STK10 | 0.87085621 |
| 54 | BRAF | 0.86972302 |
| 55 | GRK1 | 0.86430879 |
| 56 | MTOR | 0.85293622 |
| 57 | GSK3A | 0.82582856 |
| 58 | BCR | 0.81807872 |
| 59 | ICK | 0.79055997 |
| 60 | PRKD3 | 0.77917028 |
| 61 | PDPK1 | 0.77116446 |
| 62 | PKN2 | 0.76600625 |
| 63 | DAPK3 | 0.75945357 |
| 64 | RPS6KA4 | 0.74285736 |
| 65 | PLK4 | 0.72757017 |
| 66 | PKN1 | 0.72569376 |
| 67 | ROCK1 | 0.72394152 |
| 68 | MAP2K1 | 0.71139987 |
| 69 | AKT3 | 0.71110945 |
| 70 | AKT2 | 0.70859627 |
| 71 | MAP3K13 | 0.70006222 |
| 72 | CAMK2B | 0.69493236 |
| 73 | ROCK2 | 0.68992781 |
| 74 | PRKACG | 0.67908234 |
| 75 | CSK | 0.67149588 |
| 76 | TTK | 0.66776026 |
| 77 | CDK4 | 0.64883011 |
| 78 | BMPR2 | 0.64573074 |
| 79 | PRKD1 | 0.63071706 |
| 80 | CDC42BPA | 0.62462023 |
| 81 | EPHB1 | 0.62409179 |
| 82 | GRK5 | 0.62367937 |
| 83 | PDGFRA | 0.62164812 |
| 84 | DYRK1A | 0.60776889 |
| 85 | PAK2 | 0.58881626 |
| 86 | STK4 | 0.58559010 |
| 87 | MAP3K11 | 0.56511609 |
| 88 | PTK2B | 0.55023338 |
| 89 | CAMK2G | 0.51923737 |
| 90 | LMTK2 | 0.50734245 |
| 91 | STK16 | 0.50392761 |
| 92 | NUAK1 | 0.49902365 |
| 93 | MAPK12 | 0.49816951 |
| 94 | PAK4 | 0.49763561 |
| 95 | PRKD2 | 0.47211507 |
| 96 | KSR2 | 0.46009173 |
| 97 | LRRK2 | 0.44746577 |
| 98 | OXSR1 | 0.43841980 |
| 99 | MAP2K3 | 0.42751646 |
| 100 | PINK1 | 0.42386348 |
| 101 | MAPKAPK5 | 0.41759948 |
| 102 | FLT3 | 0.41584744 |
| 103 | NEK1 | 0.41581599 |
| 104 | WNK1 | 0.40979385 |
| 105 | MUSK | 0.40018352 |
| 106 | NEK9 | 0.39443949 |
| 107 | ADRBK1 | 0.39168251 |
| 108 | PAK1 | 0.38684706 |
| 109 | MKNK2 | 0.38684161 |
| 110 | SCYL2 | 0.38545087 |
| 111 | EIF2AK1 | 0.38108044 |
| 112 | MAPK7 | 0.37495000 |
| 113 | AURKA | 0.37404972 |
| 114 | PBK | 0.37378165 |
| 115 | DYRK2 | 0.37300754 |
| 116 | CDK12 | 0.37197309 |
| 117 | CAMKK2 | 0.37174367 |
| 118 | PRKACB | 0.37000827 |
| 119 | FGFR1 | 0.36658161 |
| 120 | BUB1 | 0.35230337 |
| 121 | TESK2 | 0.34562766 |
| 122 | MAPKAPK2 | 0.34128838 |
| 123 | AURKB | 0.33923152 |
| 124 | WNK4 | 0.33645701 |
| 125 | PTK2 | 0.33643399 |
| 126 | EPHA3 | 0.33378150 |
| 127 | BMX | 0.33255880 |
| 128 | CSNK1A1L | 0.33005258 |
| 129 | INSR | 0.32898594 |
| 130 | GRK7 | 0.32663973 |
| 131 | CDK6 | 0.31887754 |
| 132 | SIK1 | 0.31554344 |
| 133 | IGF1R | 0.30934684 |
| 134 | STK38 | 0.30918468 |
| 135 | RIPK1 | 0.30714147 |
| 136 | NLK | 0.30705250 |
| 137 | MKNK1 | 0.30573954 |
| 138 | NEK2 | 0.29289473 |
| 139 | MST1R | 0.29109757 |
| 140 | RPS6KB2 | 0.28567222 |
| 141 | TGFBR1 | 0.28532427 |
| 142 | PRKCE | 0.28523177 |
| 143 | CAMK1D | 0.28339526 |
| 144 | PRKG1 | 0.27967220 |
| 145 | MAPK3 | 0.26499879 |
| 146 | MAPK1 | 0.26465843 |
| 147 | NTRK1 | 0.26437064 |
| 148 | EIF2AK2 | 0.25715155 |
| 149 | CSNK1G1 | 0.25420494 |
| 150 | MELK | 0.24299235 |
| 151 | PLK3 | 0.23242994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 5.54402139 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 4.86716400 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 4.83913289 |
| 4 | Protein digestion and absorption_Homo sapiens_hsa04974 | 4.08581578 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.01684398 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.26210597 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.16503535 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.14135197 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.67285590 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.56085275 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55745322 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.44556232 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33328835 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.28469429 |
| 15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.28293645 |
| 16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.20850119 |
| 17 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.17147592 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.01403344 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94946878 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.90991572 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.89072638 |
| 22 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.88309942 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.86878184 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.81076335 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.75178000 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74177037 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.67350293 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64559274 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58997854 |
| 30 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.55799057 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54788450 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53807802 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50520719 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.48951547 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.48798538 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48563960 |
| 37 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.46159675 |
| 38 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.41306011 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32262754 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.25867134 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.24450981 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23643480 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22222695 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18460718 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 1.15868899 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15397395 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.12523941 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12167430 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06068015 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05035436 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.04805067 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00099025 |
| 53 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.97621552 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97209083 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93633040 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92774676 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.91595890 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.90933669 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89272917 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.82237897 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80711460 |
| 62 | Melanoma_Homo sapiens_hsa05218 | 0.79510945 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.79232854 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78120255 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76139287 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75976225 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75719520 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74559897 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.73503722 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73373216 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72404994 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71554422 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71544187 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71386484 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69258972 |
| 76 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.69224273 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69190471 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66832176 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.66075758 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66053828 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63978089 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63907742 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61449843 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60636661 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59222719 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59144157 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59091591 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58811030 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58443493 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57701235 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56197235 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55365547 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54541906 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53448085 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.52793413 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52021823 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.49235770 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49176365 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.48119157 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47550363 |
| 101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47488460 |
| 102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45938500 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44947637 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44544584 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.44489971 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43523015 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.43480239 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42253653 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42084028 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.38949037 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38832586 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.38520679 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37806521 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37354312 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.36737249 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35583214 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.33779881 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33704937 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | 0.33220238 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33200353 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33015347 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32651302 |
| 123 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32179896 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32154743 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32151497 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31918896 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30996246 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30579033 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30557152 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.29184492 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29171162 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27938798 |
| 133 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27367296 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26543710 |
| 135 | Apoptosis_Homo sapiens_hsa04210 | 0.26523805 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25763504 |
| 137 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24969263 |
| 138 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24947120 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24507774 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24193175 |
| 141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24005828 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.22837516 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21938723 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21607473 |
| 145 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19683943 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19371285 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.16271409 |
| 148 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15750992 |
| 149 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14135773 |

